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Today, pathophysiological mechanisms leading to in-
creased cardiovascular risk in patients with chronic kidney 
disease (CKD) have not been fully understood, but there 
is hard evidence of a close link between heart and kidney 
[1–4]. Interaction between kidney diseases and the cardio-
vascular system, so called “cardiorenal syndrome” (CRS) 
[1–3], has been much discussed recently. Cardiorenal syn-
drome involves a variety of acute and chronic diseases in 
which the dysfunction of either the heart or kidneys may 
cause the failure of the other organ [3, 4]. CRS type 4, or 
chronic renocardiac syndrome, is defined as “chronic kid-
ney pathology leading to heart failure”, refers to the deve-
lopment of cardiovascular system pathology at any stage of 
CKD [1, 2, 4, 5]. Patients with CKD are particularly prone 
to developing cardiac dysfunction due to the high preva-
lence of cardiovascular risk factors in this population, but 
the contribution of specific risk factors should be taken into 
account [5]. The most important risk factor for developing 
renocardiac disorders is increased blood pressure (BP), both 
in adults and children [1, 4, 6].
A number of studies have shown that high BP plays the 
role of an independent risk factor for rapid reduction in glo-
merular filtration rate (GFR) in patients with renal diseases 
[6–9]. BP monitoring is important for the management of 
patients with CKD, both for the conventional cardiovas-
cular risk reduction and long-term preservation of kidney 
function [8]. The parameters of 24-hour ambulatory blood 
pressure monitoring (ABPM) have more pronounced pre-
dictive value for the diagnosis of target organ damage than 
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24-hour blood pressure profile in children with chronic 
pyelonephritis and chronic kidney disease stages I–III
Abstract. Background. Blood pressure (BP) monitoring is important for the management of patients with 
chronic kidney disease (CKD), both for the conventional cardiovascular risk reduction and long-term 
preservation of kidney function. The purpose was to study the features of 24-hour blood pressure profile 
in children with chronic pyelonephritis (CPN) and CKD stages ²–²²². Materials and methods. A total of 94 
patients aged from 6 to 17 years with chronic pyelonephritis in remission and CKD stages ²–²²² were exam-
ined.  24-hour ambulatory blood pressure monitoring (ABPM) was carried out followed by mathematical 
processing. Results. Thus, a comparative analysis of the systolic (SBP) and diastolic blood pressure (DBP) 
indicators obtained within a single BP measurement and during 24-hour ABPM showed their differences 
in 25.5 % of cases. According to ABPM findings, 22.3 % of CKD children demonstrated elevated BP and 
34.0 % — arterial hypertension (ÀÍ). It was found that the relative number of patients with sustained and 
labile AH gradually increased with a decrease in renal functions (mild-to-moderate CKD progression). The 
analysis of night-time BP dipping degree in patients with CKD revealed a gradual decrease in the relative 
number of patients with optimal BP dipping for both SBP (from 61.7 % in CKD stage I to 47.1 % in CKD stage 
III) and DBP (53.2 and 11.8 %, respectively; ð = 0.0049). Night-peakers with night-time stable elevation of SBP 
(11.8 %) and DBP (29.4 %) were the patients with CKD stage III. Conclusions. The number of hypertensive pa-
tients increases among CPN children during CKD progression. AH in children with progressive nephropathy 
is characterized by a greater contribution from DBP and stable elevation of night-time BP.
Keywords: blood pressure; 24-hour blood pressure profile; children; chronic pyelonephritis; chronic kidney 
disease
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the indicators determined at a single office/home BP mea-
surement [8, 10].
Normal BP values assessed by a single office measure-
ment cannot rule out masked arterial hypertension (AH), 
night-time hypertension and other deviations from the norm 
in children with CKD [8, 10]. 2017 American Academy of 
Pediatrics Guidance recommends the 24-hour ABPM for 
children and adolescents with CKD, regardless of routine 
office BP measurements, at least once a year [8, 11].
The purpose of our work was to determine the features 
of 24-hour blood pressure profile in children with chronic 
pyelonephritis (CPN) and chronic kidney disease stages 
І–ІІІ.
Materials and methods
A total of 94 patients aged from 6 to 17 years (41 boys, 
53 girls) with chronic pyelonephritis and CKD stages І–
ІІІ were examined. The control group consisted of 78 ap-
parently healthy children of the corresponding age and 
sex. All the patients received inpatient treatment in the 
Nephrology Department of SI “Dnipropetrovsk Regional 
Children’s Clinical Hospital of DRC”. The planned clini-
cal study was approved by the Bioethics Committee of the 
SI “Dnipropetrovsk Medical Academy of the Ministry of 
Health of Ukraine” and conducted in accordance with the 
1975 version of the Declaration of Helsinki. The criteria 
for inclusion in the study were: the presence of a voluntary 
informed consent of a child and his/her parents for study 
participation; age of patients from 6 years to 17 years 11 
months and 29 days; the presence of verified diagnoses of 
CPN and CKD stages І–ІІІ; the absence of clinical and 
laboratory signs of CPN exacerbation. The criteria for ex-
clusion of patients from the study were: refusal of a child or 
his/her parents to participate in the study; the presence of 
congenital heart disease or other primary cardiac diseases, 
acute infections, diabetes mellitus, essential or neuroendo-
crine AH.
Based on the renal functions state, children were divided 
into respective groups: group 1 — 47 patients with CKD 
stage I; group 2 — 30 patients with CKD stage II; group 3 — 
17 children with CKD stage III.
The office BP measurement was performed three times 
with an interval of 2–3 minutes after rest for 10–15 minutes 
beforehand in a comfortable sitting position using a tono-
meter with an appropriately fitted cuff corresponding to the 
age and arm circumference.
24-hour ABPM was carried out using the software-
hardware system “Cardiotechnica-04-BP-1” (ZAO “IN-
CART”, St. Petersburg, RF). The following quantitative 
parameters were assessed analyzing the 24-hour ABPM re-
sults: average 24-hour BP, mean daytime and mean night-
time values of systolic (SBP) and diastolic BP (DBP), mean 
BP, pulse BP, heart rate, maximum and minimum values of 
SBP, DBP and heart rate, indexes of SBP and DBP load 
at daytime and night-time (time rate index), the magnitude 
and velocity of SBP and DBP morning surge.
Daytime and night-time SBP and DBP variability was 
determined by the standard deviation of these indicators 
from the mean value. The degree of nocturnal BP dipping 
or daily index (the ratio of average daytime BP to average 
night-time BP values, SBP daily index, DBP daily index) 
were also calculated. The average 24-hour, mean daytime 
and mean night-time SBP and DBP values were assessed 
using percentile tables (percentiles 5, 50, 90, 95) depending 
on the child’s gender and height.
When evaluating BP, normal BP, elevated BP and hyper-
tension were identified using the 2017 American Academy 
of Pediatrics Guidance [11]. Sustained AH was diagnosed 
at an average 24-hour BP level above 95th percentile with the 
index of BP load of more than 50 %. Labile AH was deter-
mined if the index of BP load ranged from 25 to 50 %, but an 
average 24-hour BP level was below 95th percentile.
By the value of BP daily index, 4 variants were distin-
guished: dippers — the daily index 10–22 %; non-dippers — 
daily index 0–10 %; over-dippers — daily index over 22 %; 
night-peakers — daily index less than 0 %.
The results were statistically analyzed using the Statis-
tica 8.0 package. The Shapiro-Wilk normality test was used 
to check the normal distribution of variables according to 
the Gaussian distribution model. Given the non-Gaussian 
distribution in most of the samples, the results were pre-
sented as median (Me) and interquartile range (Q25; Q75). 
The mean values between groups were compared using the 
Mann-Whitney test. A value of p < 0.05 was considered sta-
tistically significant.
Results
According to the results of a single BP measurement, 
elevated BP was diagnosed in 9.6 % and AH in 21.3 % of 
patients, while 24-hour ABPM revealed elevated BP in 
22.3 % and AH in 34.0 % of patients. Thus, a comparative 
analysis of the SBP and DBP indicators, obtained at a single 
BP measurement and during 24-hour ABPM, showed their 
differences in 25.5 % of cases. Masked AH was registered in 
12.8 % of patients.
The structure of BP in the examined children with CPN 
and CKD is presented in Table 1.
Analysis of the main integrated indicators determined 
during 24-hour ABPM in children with CPN and CKD 
found the relative number of AH patients gradually in-
creased with a decrease in renal functions (mild-to-mode-
rate CKD progression).
The maximum pathological changes occurred in the 
group of children with CPN and CKD stage III, as AH 
was diagnosed in more than half of the patients — 58.8 %. 
AH stage I prevailed in the structure of AH (21.3, 26.7 and 
41.2 % in CKD stage І, ІІ and ІІІ, respectively).
The relative number of patients with stable and labile 
AH gradually increased with CKD progression (Fig. 1).
In the overall structure of hypertension, labile hyperten-
sion prevailed in CPN patients (53.1 %), stable hyperten-
sion was detected somewhat less frequently — in 46.9 % of 
children. The proportion of hypertensive patients (stable 
AH + labile AH) in the group of children with CKD stage 
III was statistically significantly higher than in patients with 
CKD stage I (58.8 and 25.5 %, respectively; p = 0.0172) and 
in those with CKD II stage (58.8 and 33.4 %, respectively; 
p = 0.0290).
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The analysis of night-time BP dipping degree in CKD 
patients revealed a gradual decrease in the relative num-
ber of patients with optimal BP dipping (dippers) in CKD 
mild-to-moderate progression for both SBP (from 61.7 % 
in CKD stage I to 47.1 % in CKD stage III) and DBP (53.2 
and 11.8 %, respectively; p = 0.0049) (Fig. 2).
By contrast, the relative number of patients with an in-
adequate night-time BP dipping (non-dippers) increased in 
reference to the indicators of SBP (from 29.8 % in CKD 
stage I to 41.1 % in CKD stage III) and DBP (25.5 and 
58.8 %, respectively; p = 0.0172) (Fig. 3).
Night-peakers with night-time stable elevation of SBP 
(11.8 %) and DBP (29.4 %) were detected among patients 
with CKD stage III.
The study of BP morning pattern, namely the magnitude 
and velocity of SBP and DBP morning surge, found a num-
ber of features (Tables 2, 3).
The median of SBP morning surge did not exceed the 
normative value of 56.5 mm Hg in all groups of the exa-
mined children. The median velocity of DBP morning surge 
was elevated in all examined groups, while the median of 
SBP morning surge was above the norm only in children 
with CKD stage I.
The detailed analysis found that the relative number of 
children with increased magnitude of SBP morning surge 
in CKD stage III was statistically significantly higher than 
that in case of CKD stage I (29.4 and 4.2 %, respectively; 
p = 0.0057) and CKD stage ІІ (29.4 and 3.3 %, respectively; 
p = 0.0126) (Table 3).
Table 1. The structure of 24-hour BP profile in children with CPN and CKD
BP




CKD stage ІІІ, 
n = 17
The total number 




N % N % N % N % N %
Normal 25 53.2 11 36.6 2 11.8 38 40.4 48 61.5
р1 > 0.05 р1 < 0.05
р2 > 0.05
р1 < 0.05 
р3 < 0.05
р4 < 0.05
р1 < 0.05 –
Hypotension 3 6.4 – – – – 3 3.2 23 29.5
 р1 < 0.05 – – р1 < 0.05 –
Elevated BP 7 14.9 9 30.0 5 29.4 21 22.3 7 9.0





р1 < 0.05 –
Stage І AH 10 21.3 8 26.7 7 41.2 25 26.6 – –





р1 < 0.05 –
Stage ІІ AH 2 4.2 2 6.7 3 17.6 7 7.5 – –





р1 < 0.05 –
AH in total 12 25.5 10 33.4 10 58.8 32 34.0 – –





р1 < 0.05 –
Notes: р1 – significance of differences in comparison to the control group; р2 — significance of differences 
between groups 1 and 2; р3 — significance of differences between groups 2 and 3; р4 — significance of differences 
between groups 1 and 3.
Figure 1. The frequency of sustained, labile AH and 
elevated BP in children with CPN and CKD assessed 

















Sustained AH Labile AH Elevated BP
CKD stage І CKD stage ІІ CKD stage ІІІ
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The proportion of children with increased velocity of 
SBP and DBP morning surge did not differ statistically sig-
nificantly between examined groups, but the relative num-
ber of patients with increased velocity of DBP mor ning 
surge was significantly higher in CKD stage II (63.3 and 
33.3 %, respectively; p = 0.0256) and CKD stage ІІІ (58.8 
and 23.5 %, respectively; p = 0.0465).
Discussion
AH is considered to be one of the main factors con-
tributing to the progression of CKD, increasing the risk of 
cardiovascular complications and suppressing neurocogni-
tive functions [12, 13]. Our results of BP studies suggest that 
the number of hypertensive patients increases in CKD pro-
gression towards the terminal stage of chronic renal failure. 
CKD stage І CKD stage ІI CKD stage ІIІ
Night-peakers 0.0 3.3 11.8
Over-dippers 8.5 3.3 0.0
Non-dippers 29.8 23.3 41.1













Figure 2. The ratio of 24-hour SBP profile variants
 in reference to the degree of night-time BP dipping 
in children with CPN and CKD (%)
Figure 3. The ratio of 24-hour DBP profile variants 
in reference to the degree of night-time BP dipping 
in children with CPN and CKD (%)
CKD stage І CKD stage ІІ CKD stage ІIІ
Night-peakers 0.0 3.3 29.4
Over-dippers 21.3 26.7 0.0
Non-dippers 25.5 33.3 58.8













Table 2. Indicators of SBP and DBP morning pattern in reference to the 24-hour ABPM results 
in children with CPN and CKD, Me (Lq; Uq)
Indicators
Patient groups
CKD stage І, n = 47 CKD stage ІІ, n = 30 CKD stage ІІІ, n = 17


















Note: * — р < 0.05 in comparison to normal values.
Table 3. The frequency and velocity of BP morning surge in children with CPN and CKD (%)
Indicators
Patient groups
CKD stage І, n = 47 CKD stage ІІ, n = 30 CKD stage ІІІ, n = 17
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These results are supported by the data of the CKiD study, 
which determined an increase in the number of children 
with AH and cardiovascular complications due to reduced 
kidney function [14].
Comparative analysis of 24-hour ABPM and office BP 
measurement results shows that a statistically significantly 
greater number of patients were diagnosed with AH (34.0 
and 21.3 %, respectively; p = 0.0474) and elevated BP 
(22.3 and 9.6 %, respectively; p = 0.0385) assessed by 24-
hour ABPM. The data obtained coincide with the results of 
other researchers. Thus, when comparing the results of of-
fice BP measurement and 24-hour ABPM in 359 children 
with CKD and GFR at least 30 ml/min, the latter method 
revealed a greater relative number of patients with both 
 elevated BP and AH [10].
A detailed analysis of 24-hour BP profile in children with 
CPN and CKD demonstrates DBP and night-time stably 
elevated BP to be great contributors to AH. Previous studies 
also show that masked AH is diagnosed mainly by DBP [15] 
and the detection of isolated night-time BP elevation [16]. 
These data can be an argument to conclude that BP normal 
level assessed by a single office measurement does not al-
low ruling out masked AH in CKD children. Therefore, it is 
now recommended to perform 24-hour ABPM for all CKD 
children regardless of BP level assessed by a single office BP 
measurement [17–19].
The analysis of night-time BP dipping degree in pa-
tients with CKD revealed a gradual decrease in the rela-
tive number of patients with optimal BP dipping (dippers) 
in CKD progression and thus, an increase in the number 
of non-dipper patients. Taking into consideration that 
non-dipping BP pattern is associated with suppression of 
parasympathetic nervous system activity and an increase in 
sympathetic nervous system activity throughout the night, 
it appears that hypersympathicotonia significantly influence 
not only 24-hour BP profile and AH development, but also 
CKD progression [20]. In the view of most clinicians, the 
non-dipping circadian rhythm of BP in CKD patients is 
closely linked to cardiovascular complications, particularly, 
left ventricular hypertrophy [21].
Although statistically significant between-groups diffe-
rences in indices of BP morning surge were not obtained by 
a majority of comparisons, the fact of an increase in magni-
tude and velocity of BP morning surge in CKD children with 
reduced renal function deserves attention. It should be noted 
that the morning BP surge is mediated by rapid sympathetic 
nervous system activation with the development of vasocon-
striction [7, 22]. Also, in the morning, the endothelial func-
tion decreases, and the level of thrombogenic factors increa-
ses [23, 24]. All these processes can result in cardiovascular 
events in CKD patients [25]. So, the presence of increased 
and rapid morning BP surge in CKD patients considers them 
not only as a risk group for future cardiovascular events but 
also indicates an increased risk of target organ damage.
Conclusions
The number of hypertensive patients increases among 
CPN children at the stage of CKD progression. AH in 
children with progressive nephropathy is characterized by 
a greater contribution from DBP and stable elevation of 
night-time BP. Increased night-time BP can be considered 
as an indicator of AH stability and an additional risk fac-
tor for cardiovascular complications in this category of pa-
tients. Indicators of the 24-hour ABPM, especially which 
are tied to the circadian rhythm of BP, demonstrate a sig-
nificant role of the autonomic nervous system dysfunction 
in the development and progression of CKD as well as car-
diovascular pathology.
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Äîáîâèé ïðîô³ëü àðòåð³àëüíîãî òèñêó â ä³òåé ³ç õðîí³÷íèì ï³ºëîíåôðèòîì 
òà õðîí³÷íîþ õâîðîáîþ íèðîê I–III ñòàä³é
Резюме. Актуальність. У веденні пацієнтів із хронічною хво-
робою нирок (ХХН) важливе значення як для зниження тра-
диційного серцево-судинного ризику, так і для збереження за-
лишкової функції нирок протягом тривалого часу має контроль 
артеріального тиску (АТ). Мета роботи: вивчити особливості 
добового профілю артеріального тиску в дітей із хронічним 
пієлонефритом (ХПН) і І–ІІІ стадією ХХН. Матеріали та ме-
тоди. Обстежені 94 дитини віком від 6 до 17 років із хронічним 
пієлонефритом поза загостренням і з ХХН I–III стадії. Про-
водили добове моніторування АТ із наступною математичною 
обробкою результатів. Результати. При порівняльному аналізі 
показників АТ, отриманих при разовому вимірюванні та при 
проведенні ДМАТ, виявлено їх розбіжність у 25,5 % випадків. 
За даними ДМАТ, у дітей з ХПН в цілому підвищений АТ ре-
єструвався у 22,3 % хворих, АГ — у 34,0 %. Встановлено, що зі 
зниженням ниркових функцій (легкий або помірний ступінь 
ХХН) поступово збільшувалась відносна кількість хворих зі 
стабільною та лабільною АГ. Аналіз ступеня нічного зниження 
АТ у пацієнтів із ХПН виявив поступове зменшення відносної 
кількості пацієнтів з оптимальним рівнем зниження як систо-
лічного АТ (від 61,7 % при ХХН І ст. до 47,1 % при ХХН ІІІ ст.), 
так і діастолічного АТ (53,2 і 11,8 % відповідно; р = 0,0049). Се-
ред хворих із ХХН ІІІ стадії реєстрували пацієнтів night-peakers, 
які мали стійке підвищення систолічного (11,8 %) та діастоліч-
ного АТ (29,4 %) вночі. Висновки. Під час прогресування ХХН 
серед дітей із ХПН зростає кількість пацієнтів із підвищеним 
АТ та АГ. Характерними ознаками АГ у цієї категорії пацієнтів 
є суттєвіший внесок діастолічної складової та стійке підвищен-
ня нічного АТ.
Ключові слова: артеріальний тиск; добове моніторування 
артеріального тиску; діти; хронічний пієлонефрит; хронічна 
хвороба нирок
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Резюме. Актуальность. В ведении пациентов с хронической 
болезнью почек (ХБП) важное значение как для снижения 
традиционного сердечно-сосудистого риска, так и для со-
хранения остаточной функции почек в течение длительного 
времени имеет контроль артериального давления (АД). Цель 
работы: изучить особенности суточного профиля АД у детей 
с хроническим пиелонефритом (ХПН) с І–ІІІ стадией ХБП. 
Материалы и методы. Обследованы 94 ребенка в возрасте от 
6 до 17 лет с хроническим пиелонефритом вне обострения и 
ХБП I–III стадии. Проводилось суточное мониторирование 
артериального давления (СМАД) с последующей математиче-
ской обработкой результатов. Результаты. При сравнитель-
ном анализе показателей АД, полученных при разовом изме-
рении и при проведении СМАД, выявлено их расхождение 
в 25,5 % случаев. По данным СМАД, у детей с ХПН в целом 
повышенное АД регистрировалось у 22,3 % больных, АГ — у 
34,0 %. Установлено, что со снижением функции почек (лег-
кая или умеренная степень ХБП) постепенно увеличивалось 
относительное количество больных со стабильной и лабиль-
ной артериальной гипертензией (АГ). Анализ степени ночного 
снижения АД у пациентов с ХПН показал постепенное умень-
шение относительного количества пациентов с оптимальным 
уровнем снижения как систолического АД (от 61,7 % при ХБП 
I стадии до 47,1 % при ХБП III стадии), так и диастолического 
АД (53,2 и 11,8 % соответственно; р = 0,0049). Среди больных 
с ХБП III стадии регистрировались пациенты night peakers, ко-
торые имели устойчивое повышение систолического (11,8 %) 
и диастолического АД (29,4 %) ночью. Выводы. Во время про-
грессирования ХБП среди детей с ХПН увеличивается ко-
личество пациентов с повышенным АД и АГ. Характерными 
признаками АГ у этой категории пациентов являются суще-
ственный вклад диастолической составляющей и устойчивое 
повышение ночного АД.
Ключевые слова: артериальное давление; суточное мони-
торирование артериального давления; дети; хронический пи-
елонефрит; хроническая болезнь почек
